Innovent Biologics

1 follower


Innovent Biologics, Inc. is a China-based biopharmaceutical company. The Company's main products include PD-1 antibody; bevacizumab (Avastin) biosimilar, IBI-305; rituximab (MabThera/Rituxan) biosimilar, IBI-301; and adalimumab (Humira) biosimilar, IBI-303.

Industries

Headquarters

Suzhou, China

Employees

1,001-5,000

Links

Org chart

Yu Dechao
Founder, Chairman & CEO

Yu Dechao

Collapse
Liu Yongjun
President
Gao Changshou
Chief Technology Officer & SVP
Xi Hao
Executive Director & CFO
Zhang Qian
Chief Talent Officer
Wang Dongming
SVP, Quality
Astrid Maria Dahl
Chief Operating Officer And Head Of Innovent Biologics (europe)
Yong Jun Liu
President
Guoqiang Hu
Senior Vice President
Kenneth Kang
Suzhou M1 General Manager, Senior VP
Kaiming Wei
Senior Legal Counsel